TY - JOUR A1 - Hartl, Maximilian J. A1 - Bodem, Jochen A1 - Jochheim, Fabian A1 - Rethwilm, Axel A1 - Rösch, Paul A1 - Wöhrl, Birgitta M. T1 - Regulation of foamy virus protease activity by viral RNA JF - Retrovirology N2 - No abstract available. KW - Virologie Y1 - 2011 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-142248 VL - 8 IS - Suppl. 1 ER - TY - JOUR A1 - Schneider-Schaulies, Sibylle A1 - Liebert, UG A1 - Baczko, K, A1 - ter Meulen, V. T1 - Molecular Biological Analysis of Measles Virus Gene Expression in the CNS of Acutely and Persistently Infected Rat Brain Cells KW - Virologie Y1 - 1988 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-81784 ER - TY - JOUR A1 - Hess, Michael A1 - Stritzker, Jochen A1 - Härtl, Barbara A1 - Sturm, Julia A1 - Gentschev, Ivaylo A1 - Szalay, Aladar T1 - Bacterial glucuronidase as general marker for oncolytic virotherapy or other biological therapies N2 - Background: Oncolytic viral tumor therapy is an emerging field in the fight against cancer with rising numbers of clinical trials and the first clinically approved product (Adenovirus for the treatment of Head and Neck Cancer in China) in this field. Yet, until recently no general (bio)marker or reporter gene was described that could be used to evaluate successful tumor colonization and/or transgene expression in other biological therapies. Methods: Here, a bacterial glucuronidase (GusA) encoded by biological therapeutics (e.g. oncolytic viruses) was used as reporter system. Results: Using fluorogenic probes that were specifically activated by glucuronidase we could show 1) preferential activation in tumors, 2) rena l excretion of the activated fluorescent compounds and 3) reproducible detection of GusA in the serum of oncolytic vaccinia virus treated, tumor bearing mice in several tumor models. Time course studies revealed that reliable differentiation between tumor bearing and healthy mice can be done as early as 9 days post injection of the virus. Regarding the sensitivity of the newly developed assay system, we could show that a single infected tumor cell could be reliably detected in this assay. Conclusion: GusA therefore has the potential to be used as a general marker in the preclinical and clinical evaluation of (novel) biological therapies as well as being useful for the detection of rare cells such as circulating tumor cells KW - Virologie KW - beta-glucuronidase KW - oncolytic virus KW - cancer KW - reporter KW - fluorescent probe Y1 - 2011 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-69163 ER - TY - JOUR A1 - Avota, Elita A1 - Gassert, Evelyn A1 - Schneider-Schaulies, Sibylle T1 - Cytoskeletal Dynamics: Concepts in Measles Virus Replication and Immunomodulation N2 - In common with most viruses, measles virus (MV) relies on the integrity of the cytoskeleton of its host cells both with regard to efficient replication in these cells, but also retention of their motility which favors viral dissemination. It is, however, the surface interaction of the viral glycoprotein (gp) complex with receptors present on lymphocytes and dendritic cells (DCs), that signals effective initiation of host cell cytoskeletal dynamics. For DCs, these may act to regulate processes as diverse as viral uptake and sorting, but also the ability of these cells to successfully establish and maintain functional immune synapses (IS) with T cells. In T cells, MV signaling causes actin cytoskeletal paralysis associated with a loss of polarization, adhesion and motility, which has been linked to activation of sphingomyelinases and subsequent accumulation of membrane ceramides. MV modulation of both DC and T cell cytoskeletal dynamics may be important for the understanding of MV immunosuppression at the cellular level. KW - Virologie KW - measles virus KW - cytoskeleton KW - sphingomyelinase Y1 - 2011 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-69092 ER - TY - JOUR A1 - Schneider-Schaulies, Sibylle A1 - Schneider-Schaulies, Jürgen A1 - Schuster, A. A1 - Bayer, M. A1 - Pavlovic, J. A1 - ter Meulen, V. T1 - Cell type specific MxA-mediated inhibition of measles virus transcription in human brain cells N2 - No abstract available KW - Virologie Y1 - 1994 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-62255 ER - TY - JOUR A1 - Segev, Y. A1 - Rager-Zisman, B. A1 - Isakov, N. A1 - Schneider-Schaulies, Sibylle A1 - ter Meulen, V. A1 - Udem, S. A. A1 - Segal, S. A1 - Wolfson, M. T1 - Reversal of measles virus mediated increase of phosphorylating activity in persistently infected mouse neuroblastoma cells by anti measles antibodies N2 - No abstract available KW - Virologie Y1 - 1994 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-62362 ER - TY - JOUR A1 - Schnorr, J. J. A1 - Schneider-Schaulies, Sibylle A1 - Simon-Jödicke, A. A1 - Pavlovic, J. A1 - Horisberger, M. A. A1 - ter Meulen, V. T1 - MxA dependent inhibition of Measles Virus glycoprotein synthesis in a stably transfected human monocytic cell line N2 - No abstract available KW - Virologie Y1 - 1993 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-62353 ER - TY - JOUR A1 - Schneider-Schaulies, Sibylle A1 - Liebert, U. G. A1 - Rager-Zisman, B. A1 - Wolfson, M. A1 - ter Meulen, V. T1 - Antibody-dependent transcriptional regulation of measles virus in persistently infected neural cells N2 - No abstract available KW - Virologie Y1 - 1992 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-62329 ER - TY - JOUR A1 - Kraus, E. A1 - Schneider-Schaulies, Sibylle A1 - Miyasaka, M. A1 - Tamatani, T. A1 - Sedgwick, J. T1 - Augmentation of major histocompatibility complex class I and ICAM-1 expression on glial cells following measles virus infection: evidence for the role of type-1 interferon N2 - No abstract available KW - Virologie Y1 - 1991 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-62301 ER - TY - JOUR A1 - Schneider-Schaulies, Sibylle A1 - Kreth, H. W. A1 - Hofmann, G. A1 - Billeter, M. A. A1 - ter Meulen, V. T1 - Expression of measles virus RNA in peripheral blood mononuclear cells of patients with measles, SSPE, and autoimmune diseases N2 - No abstract available KW - Virologie Y1 - 1991 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-62297 ER -